Browse by author
Lookup NU author(s): Dr Petros PerrosORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.Background: Treatment of simple goiter (SG) growing over time with thyroid hormone (TH) therapy is discouraged by international guidelines. Purpose: To ascertain views of European thyroid specialists about TH treatment for euthyroid patients with growing SG and explore associations with management choice. Methods: Online survey on the use of TH for growing SG among thyroid experts from 28 European countries. Results: The response rate was 31.5% (5430/17,247). Most respondents were endocrinologists. Twenty-eight percent asserted that TH therapy may be indicated in euthyroid patients with a growing SG. National and regional differences were noted, from 7% of positive responses in The Netherlands to 78% in Czech Republic (p < 0.0001). TH was more frequently prescribed by respondents over 40 years old (OR 1.77, 2.13, 2.41 if 41–50, 51–60, >60, respectively), and working in areas of former iodine insufficiency (OR 1.24, 95% CI 1.03–1.50). TH was less frequently prescribed by endocrinologists (OR 0.77, 95% CI 0.62-0.94) and respondents working in Southern Europe (OR 0.40, 95% CI 0.33–0.48), Northern Europe (OR 0.28, 95% CI 0.22–0.36) and Western Asia (OR 0.16, 95% CI 0.11–0.24) compared to Western Europe. Associations with respondents’ sex, country, availability of national thyroid guidelines, and gross national income per capita were absent or weak. Conclusions: Almost a third of European thyroid specialists support treating SG with TH, contrary to current guidelines and recommendations. This calls for urgent attention.
Author(s): Papini E, Attanasio R, Zarkovic M, Nagy EV, Negro R, Perros P, Galofre JC, Cohen CA, Akarsu E, Alevizaki M, Ayvaz G, Bednarczuk T, Beleslin BN, Berta E, Bodor M, Borissova AM, Boyanov M, Buffet C, Burlacu M-C, Ciric J, Diez JJ, Dobnig H, Fadeyev V, Field BCT, Fuhrer-Sakel D, Hakala T, Jiskra J, Kopp PA, Krebs M, Krsek M, Lantz M, Lazurova I, Leenhardt L, Luchytskiy V, Puga FM, McGowan A, Melo M, Metso S, Moran C, Morgunova T, Niculescu DA, Peric B, Planck T, Robenshtok E, Rosselet PO, Ruchala M, Riis KR, Shepelkevich A, Tronko M, Unuane D, Vardarli I, Visser WE, Vryonidou A, Younes YR, Hegedus L
Publication type: Article
Publication status: Published
Journal: Endocrine
Year: 2025
Volume: 87
Pages: 262-272
Print publication date: 01/01/2025
Online publication date: 31/08/2024
Acceptance date: 08/08/2024
ISSN (print): 1355-008X
ISSN (electronic): 1559-0100
Publisher: Springer
URL: https://doi.org/10.1007/s12020-024-04002-z
DOI: 10.1007/s12020-024-04002-z
Altmetrics provided by Altmetric
